By Topic

PET imaging of tumor integrin expression

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
W. Cai ; Dept. of Radiol., Stanford Univ. Sch. of Medicine, CA, USA ; X. Chen

The expression of integrin αvβ3 on sprouting capillary cells and their interaction with specific extracellular matrix ligands play a key role in tumor angiogenesis and metastasis. In several malignancies, tumor expression of integrin αvβ3 correlates well with tumor progression. Non-invasive imaging methods to visualize and quantify integrin αvβ3 expression in vivo are crucial for the success of anti-angiogenic therapy targeting integrin. Suitably labeled RGD peptides (potent integrin αvβ3 antagonists) and antibodies have been developed for PET, SPECT and NIR fluorescence imaging of small animals. Due to the high sensitivity and adequate spatial and temporal resolution of PET, development of PET probes for integrin expression imaging has been the mainstay of active research. We improved the tumor targeting efficacy and in vivo pharmacokinetics by applying polyvalency effect and designed 18F- and 64Cu-labeled dimeric and multimeric RGD peptides for both imaging and imaging-guided internal radiotherapy applications.

Published in:

2005 IEEE Computational Systems Bioinformatics Conference - Workshops (CSBW'05)

Date of Conference:

8-11 Aug. 2005